WHEN AND WHERE THIS STUDY WILL BE DONE ?

The study will be implemented in 14 sites in Mozambique and 14 sites in Tanzania. The sites were randomized to two arms: control and intervention arm.

Mozambique

NUMBER

COUNTRY

HEALTH FACILITY

REGION OR PROVINCE

1 Mozambique Centro de Saúde de DONDO Sofala
2 Mozambique Centro de Saúde de CHINGUSSURA Sofala
3 Mozambique Centro de Saúde de NHACONJO Sofala
4 Mozambique Centro de Saúde de MUNHAVA Sofala
5 Mozambique Centro de Saúde de PONTA GEA Sofala
6 Mozambique Centro de Saúde de MANGA-LOFORTE Sofala
7 Mozambique Centro de Saúde de MAFAMBISSE Sofala
8 Mozambique Centro de Saúde de M.MASCARENHAS Sofala
9 Mozambique Centro de Saúde de MACURRUNGO Sofala
10 Mozambique Centro de Saúde de NHAMAONHA Manica
11 Mozambique Centro de Saúde de 1 DE MAIO Manica
12 Mozambique Centro de Saúde de 7 DE ABRIL Manica
13 Mozambique Centro de Saúde de VILA NOVA Manica
14 Mozambique Hospital Distrital de GONDOLA Manica

 

Tanzania

NUMBER

COUNTRY

HEALTH FACILITY

REGION OR PROVINCE

1 Tanzania IGAWILO Hospital MBEYA
2 Tanzania CHUNYA District Hospital MBEYA
3 Tanzania TUKUYU District Hospital MBEYA
4 Tanzania RUANDA Health Care Clinic MBEYA
5 Tanzania CHIMALA MISSION Hospital MBEYA
6 Tanzania ITETE District Hospital MBEYA
7 Tanzania CHALANGWA Health Care Clinic MBEYA
8 Tanzania ILEMBO Health Care Clinic MBEYA
9 Tanzania UHAI Health Care Clinic MBEYA
10 Tanzania IGOGWE Hospital MBEYA
11 Tanzania MTANILA Health Care Clinic MBEYA
12 Tanzania INYALA Health Care Clinic MBEYA
13 Tanzania SONGWE REGIONAL Hospital SONGWE
14 Tanzania IYULA Health Care Clinic SONGWE

Study recruitment will start in Q3/4 2019 and will continue over 2 years. The follow-up period for all mothers/infant pairs will include 12 weeks after birth, for HIV-infected infants months 6, 12, 18 after birth, and for a subset of HIV-exposed infants included into the long-term follow-up period including months 9 and 18 after birth.